Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IGFBP2 Antikörper (AA 180-328)

IGFBP2 Reaktivität: Human WB, IHC, ELISA Wirt: Maus Monoclonal 1F6F6 unconjugated
Produktnummer ABIN1724698
  • Target Alle IGFBP2 Antikörper anzeigen
    IGFBP2 (Insulin-Like Growth Factor Binding Protein 2, 36kDa (IGFBP2))
    Bindungsspezifität
    • 16
    • 10
    • 8
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 180-328
    Reaktivität
    • 64
    • 32
    • 31
    • 7
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 72
    • 10
    • 2
    • 1
    Maus
    Klonalität
    • 67
    • 18
    Monoklonal
    Konjugat
    • 44
    • 11
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IGFBP2 Antikörper ist unkonjugiert
    Applikation
    • 74
    • 28
    • 22
    • 16
    • 13
    • 13
    • 12
    • 11
    • 8
    • 8
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of protein IGFBP2 (aa180-328) expressed in E. coli.
    Klon
    1F6F6
    Isotyp
    IgG1
    Top Product
    Discover our top product IGFBP2 Primärantikörper
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Miyake, Hara, Yamanaka, Muramaki, Gleave, Eto: "Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential." in: Oncology reports, Vol. 13, Issue 2, pp. 341-5, (2005) (PubMed).

    Fisher, Meyer, Garber, Dealy: "Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth." in: Bone, Vol. 37, Issue 6, pp. 741-50, (2005) (PubMed).

  • Target
    IGFBP2 (Insulin-Like Growth Factor Binding Protein 2, 36kDa (IGFBP2))
    Andere Bezeichnung
    IGFBP2 (IGFBP2 Produkte)
    Synonyme
    IBP2 antikoerper, IGF-BP53 antikoerper, AI255832 antikoerper, IBP-2 antikoerper, Igfbp-2 antikoerper, mIGFBP-2 antikoerper, IGFBP-2 antikoerper, ILGFBPA antikoerper, pIGFBP-2 antikoerper, igfbp2 antikoerper, MGC65741 antikoerper, MGC76823 antikoerper, MGC174445 antikoerper, IGFBP2 antikoerper, ibp2 antikoerper, igf-bp53 antikoerper, igfbp2a antikoerper, si:ch211-2k18.3 antikoerper, insulin like growth factor binding protein 2 antikoerper, insulin-like growth factor binding protein 2 antikoerper, insulin-like growth factor binding protein 2a antikoerper, insulin-like growth factor binding protein 2b antikoerper, IGFBP2 antikoerper, Igfbp2 antikoerper, igfbp2a antikoerper, igfbp2 antikoerper, igfbp2b antikoerper
    Hintergrund

    Description: IGFBP2: insulin-like growth factor binding protein 2. IGFBP2 is a member of the ISGBP family which bind various IGFs. IGFBP2 is overexpressed in a wide spectrum of other cancers, including glioma, prostate cancer, synovial sarcoma, neuroblastoma, colon cancer, adrenocortical cancer, lung cancer, Wilms' tumor, and hepatoblastoma. The overexpression of IGFBP2 also correlates with the aggressiveness of some tumors. IGFBP2 activates the expression of matrix metalloprotease 2, which contributes to cell invasiveness.

    Aliases: IBP2, IGF-BP53

    Gen-ID
    3485
    HGNC
    3485
    Pathways
    Myometrial Relaxation and Contraction, Growth Factor Binding, Activated T Cell Proliferation
Sie sind hier:
Kundenservice